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Background.  Epilepsy is highly prevalent in people with intellectual disabilities and mortality is 
increased in people with epilepsy generally.  This review summarises research on the comparative 
risk of mortality in people with intellectual disabilities and epilepsy compared to the general 
population, people with intellectual disabilities without epilepsy, and people with epilepsy without 
intellectual disabilities. 
Method.  Studies were identified via electronic searches using Medline, Cinahl and PsycINFO and 
cross-citations.  Information extracted from studies was tabulated and reviewed narratively. 
Results.  16 studies met the inclusion criteria.  Epilepsy was associated with increased mortality in 
people with intellectual disabilities in most studies, particularly in those experiencing recent 
seizures.  Further research is needed to substantiate some of the reported findings.     
Conclusion.  Services must be equipped with the skills and information needed to manage this 








Epilepsy is one of the most common serious brain disorders, affecting over 50 million people 
worldwide (WHO, 2005).  The prevalence of epilepsy has been estimated at approximately 0.5% to 
1.0% of the general population (Forsgren et al., 2005, Linehan et al., 2010, Joint Epilepsy Council, 
2011).  In people with intellectual disabilities, estimates of the prevalence of epilepsy vary due to 
differences in the methods used and inherent population biases (Lhatoo and Sander, 2001).  Despite 
this variation, it is clear that the prevalence of epilepsy in people with intellectual disabilities is much 
greater than in the general population (Deb, 2000).  Reported rates range, for example,  from 16.1% 
of 1,595 people with intellectual disabilities identified in South Wales (Morgan et al., 2003) to 30.7% 
in a random sample of 753 people with intellectual disabilities aged 40 or more from Ireland’s 
National Intellectual Disability Database (NIDD) (McCarron et al., 2014).  In a systematic review of 
the prevalence of chronic health conditions in children with intellectual disabilities, the most 
common condition was epilepsy (Oeseburg et al., 2011) with prevalence rates in the 14 studies 
identified ranging from 5.5% to 35.0%, with an overall weighted mean prevalence rate of 22.0% 
(95% CI 20.8, 23.2).   
 
Mortality is increased in people with epilepsy, with a recent systematic review and meta-analysis of 
38 epilepsy cohorts including over 165,000 patients finding a pooled relative risk of death of 3.3 
(95% CI 2.83, 3.92) compared to the general population (Nevalainen et al., 2014). Risk of premature 
death was lowest in idiopathic epilepsy and in people with epilepsy who had attained seizure 
freedom.   
 
People with epilepsy may have elevated mortality from external causes such as accidents including 
drowning (Bell et al., 2008).  However, Sudden Unexpected Death in Epilepsy (SUDEP) is the most 
important category of epilepsy related death (Kiani et al., 2014).  In the UK it is estimated that 500 
deaths per annum are SUDEP (Hanna et al., 2002).  Overall findings regarding the risk of SUDEP in 
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people with intellectual disabilities are inconsistent.  One systematic review of risk factors for SUDEP 
based on  27 studies  found that ‘mental retardation’ was not a risk factor for SUDEP (Monté et al., 
2007).  However, it is not clear how many studies in the review included intellectual disability as a 
risk factor.  A more recent review identified 23 articles which considered intellectual disability and 
SUDEP of which 14 found intellectual disability to be a risk factor for SUDEP and none found 
intellectual disability to be a protective factor in SUDEP (Young et al., 2014).   
 
For people with intellectual disabilities, epilepsy or convulsions has been identified as an important 
and to some extent potentially preventable cause of death (Glover and Ayub, 2010).  The study 
looked at ages and causes of death recorded on death certificates for people with intellectual 
disabilities, or conditions that can cause intellectual disabilities, who died between 2004 and 2008 in 
England.  Epilepsy or unspecified convulsions were involved in 948 deaths (13% of those identifiable) 
of people with intellectual disabilities or possibly associated conditions. In other people, they were 
involved in 0.4%. Based on Standardised Mortality Odds Ratios (an approximation of the 
Standardised Mortality Ratio), adjusting for ages at death, people where death involved epilepsy or 
unspecified convulsions were 9.7 times more likely than others to have an intellectual disability-
related condition (95% confidence interval 9.1, 10.4).   
 
The high prevalence of epilepsy in people with intellectual disabilities, combined with the increased 
risk of mortality in people with epilepsy, makes the topic of mortality in people with intellectual 
disabilities and epilepsy a pertinent one.  This review aims to summarise studies on mortality in the 
general population of people with intellectual disabilities and epilepsy and as such it excludes 
studies on specific syndromes associated with intellectual disabilities.  However, the review does 
include information relating to people with Down syndrome which is by far the most common 
chromosomal disorder associated with intellectual disability with a prevalence of approximately 1 in 
700 live births (Hatton, 2012).    Most early studies of mortality in people with intellectual disabilities 
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and epilepsy were hospital based, with an early search of the literature finding no population based-
studies including all types of intellectual disabilities on the influence of epilepsy on mortality 
(Forsgren et al., 1996).  Since that time, further studies have been conducted, including population-
based studies. In this review, we summarise existing research published from 1990 that quantifies 
the mortality of people with intellectual disabilities and epilepsy using a comparative statistic 
relative to either the general population, people with intellectual disabilities who do not have 
epilepsy, or people with epilepsy who do not have intellectual disabilities.   The statistics reported 
are defined in Table One.  For all of these, a value of one implies no difference between the two 
groups, a value of more than one indicates that the risk is greater in the target group, and a value of 
less than one indicates that the risk is less in the target group.  For example, a hazard ratio of two 
implies double the risk of dying in the target group than in the comparison group.  If the hazard ratio 
is 0.5 then the relative risk of dying in the target group is half the risk of dying in the comparison 
group.   For all of these statistics, the value can be considered statistically significant at p<.05 if the 
95% confidence interval does not include one.   
Table One Here 
Method 
Electronic literature database searches were conducted in Medline, Cinahl and PsycINFO on EBSCO.  
In addition, the reference lists of articles meeting the inclusion criteria were searched and articles 
from authors’ personal collections included.  The reference lists of key book chapters were also 
searched (Blake and Kerr, 2014, Brown, 2008, Cardoza and Kerr, 2010).  Searches were completed on 
19 June 2014.  Searches included terms relating to both mortality and prevalence to create a pool of 
articles on mortality or prevalence, with articles on prevalence being retained for a separate review.  
Searches combined terms for epilepsy, intellectual disabilities, and mortality/prevalence with the 





 Peer reviewed 
 English Language full text 
 Published from 1990; articles published before this date were excluded as they predate both 
improvements in epilepsy treatment and major changes in service provision for people with 
intellectual disabilities (Emerson, 2004).  
 Primary research.    
 Presents a comparative statistic  (e.g. relative risk, standardized mortality ratio (SMR), 
hazard ratio) on mortality in adults or children with intellectual disability and epilepsy 
compared to the general population, people with intellectual disability without epilepsy, or 
people with epilepsy without intellectual disability 
 Samples of adults or children with intellectual disabilities or samples where 50% or more 
have intellectual disabilities or mixed samples where results are disaggregated for people 
with intellectual disabilities 
Exclusion Criteria 
 Case studies 
 Case series 
 Narrative reviews 
 Studies based on neonates (new born infants up to 28 days after birth), all other age groups 
were included  
 Studies on conditions where intellectual disabilities cannot be assumed (e.g. cerebral palsy, 
autistic spectrum disorder (ASD)) where results were not disaggregated for people with 
intellectual disabilities 
 Studies on specific syndromes associated with intellectual disabilities with the exception of 
Down syndrome.   Less common syndromes were excluded, such as Fragile X syndrome 
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which has a prevalence of 1 in 4,000 males and 1 in 8,000 females (Cornish et al., 2012) and 
is not always associated with intellectual disabilities (Hatton, 2012).    
 Does not present a comparative statistic approximating relative risk (e.g. presents only 
descriptive statistics, presents chi-squared analysis).  
 
Initially, titles and abstracts were used to exclude those studies which were obviously not within the 
scope of reviews on prevalence or mortality.   Those retained for further screening were those for 
which relevance could not be assessed without accessing full text, or those that were chosen as 
potentially within scope. These studies were screened by the first and second author and discussed 
until consensus was reached on whether or not they met the inclusion criteria in relation to 
mortality in people with intellectual disabilities and epilepsy.   
 
Where multiple articles used the same sample or samples were likely to have considerable overlap 
(e.g. Day et al., 2003, Day et al., 2005), only the most recent study was included unless the studies 
were looking at different topics within the same sample (e.g. Strauss et al 2003 and Day et al 2005 
are based on the same sample source but one looks at causes of death, and one looks at whether 
seizure severity increases mortality).   
 
Information from the included studies was extracted by the first author in relation to: authors; year 
of publication; country of study; study design and study period; sample description; definition of 
epilepsy; sample size and number of deaths for those with intellectual disabilities and epilepsy; 
sample size and number of deaths for any comparison group; group that people with intellectual 
disabilities and epilepsy are compared to; statistic used (e.g. SMR); and main results.  This 
information was tabulated (see Table Two). Formal quality assessments were not undertaken as the 
intention was to include all studies reporting relevant comparative statistics and as such the review 
does not adhere to PRISMA guidelines (Moher et al., 2009). However, elements of studies relevant 
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to quality and risk of bias (i.e. sample representativeness, definition used for ascertainment of 
epilepsy, sample size) are summarised for each study in Table Two. Differences in the main 
characteristics of samples included in the studies and in the definition of epilepsy used were such 
that it was not possible to conduct meta-analysis to combine estimates of the risk of mortality.   
 
Results 
The process of identifying studies for inclusion is summarised in Figure One.  Electronic database 
searches identified a total of 1,332 references, with 1,099 remaining after removal of duplicates. 
Following the first examination of studies, 144 remained in a pool of articles relating to mortality or 
prevalence.  After examination of full text articles from this pool and the addition of articles cited 
within these and from authors’ personal collections, 16 articles met the criteria for inclusion in 
relation to mortality in people with intellectual disabilities and epilepsy.    
 
Figure One here – identification of studies here 
 
Country 
All studies were from high income countries.  There were five studies based on samples from the 
United States (Day et al., 2005, Decouflé and Autry, 2002, Nickels et al., 2012, Strauss et al., 2003, 
Walczak et al., 2001); four from the United Kingdom (UK) (Derby et al., 1996, Hermon et al., 2001, 
Kiani et al., 2014, Nashef et al., 1995); three from Finland (Mölsä, 1994, Patja et al., 2000, Sillanpää 
and Shinnar, 2010); and one from each of the Netherlands (Coppus et al., 2008), Sweden (Forsgren 
et al., 1996), Sweden and Denmark (Hill et al., 2003), and Japan (Ohwada et al., 2013).  The studies 
are summarised in Table Two.  Figures for 95% confidence intervals are given in parentheses after 
the point estimate. 





Few studies were based on samples that could be considered representative of the general 
population of people with intellectual disabilities and epilepsy.  Three studies were based on 
samples of people with Down syndrome (Coppus et al., 2008, Hermon et al., 2001, Hill et al., 2003).  
Two articles using the same data source included those with mild developmental disabilities (Day et 
al., 2005, Strauss et al., 2003).  One study included those with refractory epilepsy (Derby et al., 
1996).  Other studies were based on samples from specific settings where samples may have been 
skewed towards those with more severe epilepsy, including those attending one school for those 
with epilepsy and intellectual disabilities (Nashef et al., 1995),  an institution for those with the most 
severe disabilities (Ohwada et al., 2013), inpatients and outpatients at one centre for people with 
intellectual disabilities (Mölsä, 1994) and patients at three epilepsy centres (Walczak et al., 2001).   
 
Two studies included comprehensive samples of people with epilepsy including those with and 
without intellectual disabilities.  One study ascertained all children with epilepsy in one US county 
(Nickels et al., 2012). Similarly, one study ascertained all children with epilepsy in the catchment 
area of one hospital (Sillanpää and Shinnar, 2010).   One study used a population based cohort of 
people with developmental disabilities but this study did not give exact details for the number of 
people with intellectual disabilities and epilepsy in the sample, with the result given in Table Two 
relating to those with epilepsy and an additional unspecified developmental disability (Decouflé and 
Autry, 2002).  Three studies included representative samples of people with intellectual disabilities 
both with and without epilepsy including all those in one province of Finland (Forsgren et al., 1996), 
those on the Leicestershire Intellectual Disability Register (Kiani et al., 2014), and a nationwide 





All cause mortality in cohorts with intellectual disabilities: comparison of those with or without 
epilepsy to the general population 
In a small number of studies, figures are given in relation to all cause mortality for people with 
intellectual disabilities compared to the general population separately for those with and without 
epilepsy, or the entire sample including both those with and without epilepsy.  For those with mild 
developmental disabilities (excluding those unable to walk well or with degenerative conditions), the 
SMR for those with remote symptomatic epilepsy was 4.0 (95% CI 3.6, 4.3) compared to 1.9 (95% CI 
1.8, 2.0) for those without epilepsy (Day et al., 2005). For a representative sample of people with 
intellectual disabilities from Sweden, the SMR was 5.0 (95% CI 3.3, 7.5) for those with intellectual 
disabilities and epilepsy compared to  2.0 (95% CI 1.7, 2.3) for the entire sample (Forsgren et al., 
1996).  In this latter study, SMRs are also given in relation to seizure type and frequency:  seizure 
free in the preceding year 2.0 (95% CI 0.9, 4.7); seizures weekly or fewer 4.7 (95% CI 2.8, 7.9); 
seizures more than weekly 16.8 (95% CI 10.7, 26.5); partial seizures without seizures secondarily 
generalized 3.7 (95% CI 1.0, 13.6); seizures secondarily generalized 5.0 (95% CI 2.3, 11.0); and 
seizures generalized from onset 8.1 (95% CI 5.7, 11.5).  In a sample from England, the SMRs for 
people with intellectual disabilities and epilepsy were 3.2 (95% CI 2.7, 3.8) for men and 5.6  (95% CI 
4.6, 6.7) for women, whilst the overall SMRs  for the entire sample were 2.2 (95% CI 2.0, 2.4) for men 
and 2.8 (95% CI 2.5, 3.1) for women (Kiani et al., 2014).   Finally, the SMR for overall mortality in a 
study of pupils at one school for those with severe epilepsy and intellectual disabilities compared to 
the general population was 15.9 (95% CI 10.6, 23.0) (Nashef et al., 1995).  
 
All cause mortality in cohorts with intellectual disabilities: comparison of those with and without 
epilepsy 
More commonly, studies compare the mortality of people with intellectual disabilities and epilepsy 
to people with intellectual disabilities who do not have epilepsy in the same cohort.    For people 
with mild developmental disabilities (excluding those unable to walk well or with degenerative 
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conditions) and remote symptomatic epilepsy, compared to those in the cohort without epilepsy, 
SMRs were:  1.1 (95% CI 0.8, 1.5) for those who had not had a seizure in the last year;  2.4 (95% CI 
1.9, 3.0) for those who had had seizures in the last year but not generalised tonic-clonic (GTC) 
seizures;  2.9 (95% CI 2.4, 3.4) for those who had had GTC seizures in the last year;  and 3.7 (95% CI 
2.5, 5.4) for those who had experienced status epilepticus in the last year (Strauss et al., 2003).  In 
this cohort, those without epilepsy had an SMR of 1.7 (95% CI not stated) compared to the general 
population.  In a later analysis employing the same sample source and exclusions, the overall ratio 
SMR (the SMR for those with epilepsy divided by the SMR for those without epilepsy) was 2.1 (95% 
CI 1.9, 2.3) (Day et al., 2005).   
 
In a cohort of inpatients and outpatients of one centre for people with intellectual disabilities, the 
hazard ratio was 0.87 (95% CI 0.48, 1.61) for inpatients with epilepsy and 1.79 (95% CI 0.76, 4.25) for 
outpatients with epilepsy (Mölsä, 1994).  When type of residence was considered for outpatients, 
the risk of death due to status epilepticus was more than doubled for those in hostels.   In a cohort 
living in one institution for people with severe intellectual disabilities (excluding those with severe 
motor disabilities), the hazard ratio for those with epilepsy compared to those without was 2.39 
(95% CI 1.17, 4.92) (Ohwada et al., 2013).  This remained significant in a multivariate analysis with a 
hazard ratio of 2.79 (95% CI 1.21, 6.41).   In a nationwide population based sample, epilepsy was 
associated with reduced survival in those who were aged 2 to 9 in 1962 (hazard ratio 95% CI 0.38, 
0.84, point estimate not stated) and those who were aged 10 to 19 in 1962 (hazard ratio 95% CI 
0.10, 0.81, point estimate not stated) (Patja et al., 2000).  Finally, one study gives a hazard ratio of 
2.29 (95% CI 1.50, 3.48) for those with epilepsy compared to those without epilepsy in a cohort of 
people with Down syndrome aged 45 or more (Coppus et al., 2008). However, in multivariate 
survival analysis, age, presence of dementia, and mobility restrictions were the most important 




All cause mortality in cohorts with epilepsy: comparison of those with or without intellectual 
disabilities 
In other studies, figures are given for cohorts of people with epilepsy depending on whether or not 
they have an intellectual disability.  For those with epilepsy and an additional developmental 
disability (including but not necessarily intellectual disabilities) the all cause SMR (compared to the 
general population) was 13.2 (95% CI 7.6, 21.5);  for those with epilepsy and no other developmental 
disability the SMR was 1.5 (95% CI 0.3, 4.3) (Decouflé and Autry, 2002).   In a population based 
cohort of children with epilepsy, the hazard ratio for those with intellectual disability compared to 
those with epilepsy without intellectual disability was 20.86 (95% CI 2.76, 157.97) although only 
abnormal neurological examination was statistically significant in a multivariate model (Nickels et al., 
2012).  Similarly, for those with remote symptomatic epilepsy the hazard ratio for those with severe 
cognitive impairment was 4.1 (95% CI 2.0, 8.3) (Sillanpää and Shinnar, 2010).  However, only lack of 
5-year terminal remission was significant in multivariate analysis.  
 
Causes of Death 
A small number of studies have considered specific causes of death.  One study looked at causes of 
death in people with mild developmental disabilities (excluding those unable to walk well or with 
degenerative conditions) and remote symptomatic epilepsy which was noted to be epilepsy 
occurring in persons with developmental delay or identified brain lesions and excluding idiopathic 
epilepsy.   Ratio SMRs were obtained for those with epilepsy  compared to those without epilepsy in 
the cohort  for numerous causes of death including: epilepsy/seizures  53.1 (95% CI 28.0, 101.0);  
convulsions  25.2, (95% CI 11.7, 54.2); brain cancer  5.2 (95% CI 2.2, 12.1); accidents 2.7 (95% CI 1.9, 
3.7); respiratory diseases 1.7 (95% CI 1.2, 2.5) including aspiration pneumonia and accidental 
inhation 3.0 (95% CI 1.5, 6.0); suicide 1.5 (95% CI 0.3, 6.5); and circulatory diseases 1.3 (95% CI 1.0, 
1.7) (Day et al., 2005).   Accidental drowning was noted to be the single most significant cause of 
accidental death.  The ratio SMR for accidental drowning, which was included as part of the total 
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accidents figures, was 12.8 (95% CI 7.0, 23.2). The ratio SMR for accidental drowning in those with 
recent seizures was 15.8 (95% CI 7.2, 34.7).  Compared to the general population, the SMR for 
accidental drowning for those with recent seizures was 35.9 (95% CI not stated) compared to 2.3 
(95% CI not stated) for those with no history of epilepsy.   The authors note that the excess numbers 
of deaths due to some causes (e.g., seizures, aspiration, and accidental drowning) must at least in 
part be attributable to epilepsy.  For suicide, the SMR compared to the general population was 0.3 
(95% CI not stated) for those with epilepsy and 0.2 for those without epilepsy.  Finally, two studies 
have looked at epilepsy as a cause of death in people with Down syndrome compared to the general 
population, with one reporting a SMR of 17.3 (95% CI 7.4, 34.0) (Hermon et al., 2001) and one 
reporting a SMR of 30.4 (95% CI 13.9, 57.7) (Hill et al., 2003).   
 
SUDEP 
SUDEP as a cause of death is considered in a small number of studies.  In a sample from England, 
SMRs for SUDEP in people with intellectual disabilities compared to the general population were 
37.6 (95% CI 21.9, 60.2) for men and 52.0 (95% CI 23.8, 98.8) for women  (Kiani et al., 2014).  A study 
of pupils at one school for pupils with severe epilepsy and intellectual disabilities found an incidence 
of SUDEP of 1:295/year (Nashef et al., 1995).   It was noted that all 14 cases of SUDEP occurred when 
the pupils were not under the close supervision of the school and most were unwitnessed.  In a 
study of those with refractory epilepsy aged under 50, the relative risk of SUDEP was 1.4 (95% CI 0.3, 
8.0) for those with a computer recorded history of intellectual disabilities compared to those 
without (Derby et al., 1996).  Finally, for patients at 3 epilepsy centres intellectual disability was a 
risk factor for SUDEP after adjustment for seizure frequency (odds ratio 4.6 (95% CI 1.2, 18.0)) 







People with intellectual disabilities have an elevated risk of death compared to the general 
population, and the studies reviewed here indicate that this risk is elevated further in those who 
have co-occurring epilepsy.   The risk of death in people with intellectual disabilities and epilepsy has 
been found to be greater than in the general population by between 3.2  times for men on the 
Leicestershire Intellectual Disability Register (Kiani et al., 2014) and 16.8 times for those having 
seizures more than weekly (Forsgren et al., 1996).  In comparison, the pooled estimate for mortality 
in cohorts of people with epilepsy generally has been given as 3.3 (95% CI 2.83-3.92) (Nevalainen et 
al., 2014).  However, there are only four studies which provide a comparative statistic for those with 
intellectual disabilities and epilepsy compared to the general population (Forsgren et al., 1996, Day 
et al., 2005, Kiani et al., 2014, Nashef et al., 1995).   
 
In a number of studies comparing mortality in people with intellectual disabilities and epilepsy to 
those with intellectual disabilities without epilepsy in the same cohort, the risk of death has been 
found to be two or more times greater (Ohwada et al., 2013, Day et al., 2005, Coppus et al., 2008), 
although in the latter study only  dementia, age at baseline and restricted mobility were significant 
in multivariate analysis.  Further, the risk appears to be associated with seizure type and frequency 
with those who had not had a seizure in the last year not having an elevated risk of mortality 
(Strauss et al., 2003).   
 
For studies involving cohorts of people with epilepsy, increased risk for those with intellectual 
disabilities has been reported (Decouflé and Autry, 2002, Nickels et al., 2012).  However, in one of 
these studies, the risk associated with intellectual disabilities was not significant in multivariate 
analysis, with abnormal neurological examination being the only significant factor (Nickels et al., 
2012).  Similary, severe cognitive impairment was associated with increased risk in those with 
remote symptomatic epilepsy but on multivariate analysis only lack of five year terminal remission 
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was significant (Sillanpää and Shinnar, 2010).  This suggests that, although mortality in those with 
intellectual disabilities and epilepsy is significantly elevated, some of this excess is related to 
underlying conditions, rather than epilepsy per se.  As noted in a previous review, the higher 
mortality in those with intellectual disabilities and epilepsy is partly due to epilepsy being a marker 
of the severity of disability, and the severity of disability being a predictor of mortality (Morgan et 
al., 2001).    
 
This issue is considered in the design of one study where it is noted that in the absence of a 
controlled comparison, it may not be possible to separate the effect of epilepsy on mortality from 
the effect due to the underlying condition (Strauss et al., 2003).  To address this, Strauss et al (2003) 
included only those with mild developmental disabilities with minimal motor dysfunction who did 
not have degenerative conditions.  Based on a sample of over 80 thousand, they conclude that 
epilepsy per se is associated with an increased mortality rate, with the increased mortality risk being 
evident mainly in those with ongoing seizures.   
 
Causes of Death 
For people with mild developmental disabilities and remote symptomatic epilepsy the risk of death 
related to drowning in those with epilepsy compared to those without epilepsy in the cohort was  
12.8 times higher (Day et al., 2005).  Compared to the general population, the SMR for drowning was 
28.7 for those with remote symptomatic epilepsy, increasing to 35.9 for those with recent seizures.  
This compared to 2.3 for those with no history of epilepsy.  In the general population of people with 
epilepsy, the SMR for drowning has been estimated as 18.7 (95% CI 15.0, 23.1) in a meta-analysis of 
51 cohorts (Bell et al., 2008). These figures suggest that the risk of drowning may be greater for 
people with mild developmental disabilities and epilepsy than for the general population of people 
with epilepsy, although this is based on just one study in which the 95% confidence interval around 




Over the period 1993 to 2010, SUDEP was the second most common cause of death among adults 
with epilepsy and intellectual disabilities on the Leicestershire Intellectual Disability Register (Kiani et 
al., 2014).  Twenty-six people with intellectual disabilities died from probable or definite SUDEP.  The 
SMRs for SUDEP in adults with intellectual disabilities were 37.6 for men and 52.0 for women.  The 
authors acknowledge that this is partly attributable to the higher prevalence of epilepsy among 
people with intellectual disabilities compared to the general population (the prevalence being 19% 
in the cohort) but that even taking this into account, people with intellectual disabilities appear to be 
disproportionately disadvantaged.    Similarly, intellectual disability has been found to be a risk 
factor for SUDEP even after adjusting for seizure frequency (Walczak et al., 2001). However, for 
those with refractory epilepsy on the General Practice Research Database (GPRD, a database 
including over 4 million people registered with a GP in the UK), the relative risk of SUDEP was not 
significantly increased in people with a history of intellectual disability (Derby et al., 1996).  The 
authors acknowledge that with a small number of sudden deaths, confidence intervals are wide and 
that ascertainment of intellectual disability may not have been complete.     
 
Finally, Day et al (2005) found that in people with developmental disabilities and remote 
symptomatic epilepsy death rates were elevated for a number of causes including aspiration 
pneumonia.  However, the rate for suicide was lower than that for the general population (although 
the confidence interval for this estimate is not given).  Overall, in relation to cause of death in people 
with intellectual disabilities and epilepsy, there is a need for more research on cause of death and to 
facilitate this there is a need for better, detailed recording of death so that cause of death can be 








There are a number of limitations to this review.  Whilst studies were identified from a range of 
countries, the review is restricted to English language publications.  Very little information was 
identified regarding mortality for people with intellectual disabilities and epilepsy in low and middle 
income (LAMI) countries.  However, this is not surprising as there is little information available 
regarding mortality for people with epilepsy as a whole from LAMI countries.  This lack of data has 
been attributed to the fact that in LAMI countries, incidence studies are difficult, death certificates 
are not very reliable, autopsies are not easy to obtain, and the cause of death is not usually known 
with certainty (Carpio et al., 2005).   
 
The review has included studies relating to mortality in people with intellectual disabilities and 
epilepsy generally but has only included the most common syndrome associated with intellectual 
disability (Down syndrome).  People with intellectual disabilities are a highly heterogeneous group.  
Whilst all have a significant general impairment in intellectual functioning that is acquired during 
childhood, they differ in relation to the cause and severity of the intellectual disability which may 
result from a complex interaction between biomedical, social, behavioural and educational factors 
(Hatton, 2012).  Further, life expectancy can vary markedly between specific syndromes associated 
with intellectual disabilities.  For example, mucopolysaccharidosis type III (MPS III,  Sanfilippo 
syndrome) is associated with early death, generally during the second or third decade of life (Valstar 
et al., 2008), whilst life expectancy in fragile X syndrome is not greatly reduced (Sabaratnam, 2006). 
Future reviews could consider the issue of mortality in other syndromes that are associated with 
intellectual disabilities.  It is evident that research related to epilepsy in such syndromes, although 




All data was extracted by one reviewer and extraction of data by two reviewers independently 
would have reduced the possibility of errors.  Ideally, the same definition of epilepsy should be used 
across studies to allow comparison of mortality rates.  However, the studies identified use a variety 
of definitions of epilepsy as shown in Table Two.  Further, for some studies the confidence intervals 
around point estimates are extremely wide.   
Finally, many of the studies include cohorts for time periods that preceded the development of more 
recent anti-epileptic drugs (AEDs).  It has been noted that after a 15 year period with no new 
treatments, five drugs for epilepsy were approved from 1993 to 1997 (McKee and Bodfish, 2000).   
As such, the relevance of early cohorts to current practice may be restricted.  As poor seizure control 
appears to be a risk factor for mortality, future studies may show a diminished risk of mortality due 
to wider variety of treatment options. 
 
Conclusion 
The evidence base identified for this review is small and further research is needed to substantiate 
some of the findings reported here.  However, the evidence suggests that people with intellectual 
disabilities and epilepsy do have a substantially increased risk of mortality, particularly where 
seizures are ongoing.   It is important that services are equipped with the information and skills 
needed to manage epilepsy in this population.  A recent report provides information on reasonable 
adjustments that can be made to improve epilepsy care for people with intellectual disabilities 
(Marriott et al., 2014)   The ideas, information and examples of good practice in relation to 
reasonable adjustments provided within this report should help services improve provision for this 
highly prevalent condition and potentially reduce the excess deaths associated with epilepsy in 
people with intellectual disabilities.   
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Number of observed deaths in the target population divided by the number of 
deaths that would be expected based on death rates of a chosen standard 
population 
Relative risk or 
risk ratio 
The risk of an event (e.g. death) in the target population divided by the risk in 
the comparison group 
Hazard ratio A specific type of relative risk which is obtained using the Cox Proportional 
Hazards Model, a regression model that takes into account time until the event 
occurs 
Odds ratio The odds (number of times an event happens divided by the number of times it 
does not happen) of an event occurring in one group divided by the odds of the 
same event in another group 
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Table Two: Summary of studies on comparative risk of mortality in people with intellectual disabilities and epilepsy 
Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   










1999 to 2003, 
end date Jan 
1st 2007 
All  with DS aged 45 
or more (n=499) living 
in community or 
institutions in 4 
regions 
Epilepsy (past 














2.29 (1.50, 3.48) 
 
Not significant in multivariate survival analysis  
Day, Wu, 
Strauss et 
al 2005  
(see also 
Strauss et 
al 2003)  
US Retrospective 
analysis of 
records 1988 to 
2002 
People with mild DD 
(defined as disabling 
condition closely 
related to ID) 
receiving services 
from State of 
California Dept of 
Developmental 
Services.  Excluded 
more severe 
disabilities (unable to 
walk climb stairs 
without support, 









excluded)    




years).  406 
deaths 




















2.1 (1.9, 2.3).  
 
Cause specific (based on ICD-9 codes):  
 
Epilepsy/seizures  53.1 (28.0, 101.0);  
Convulsions 25.2, (11.7, 54.2);   
Brain cancer  5.2 (2.2, 12.1),  
Respiratory 1.7 (1.2, 2.5) 
Aspiration pneumonia  3.0 (1.5, 6.0) 
Circulatory diseases  1.3 (1.0, 1.7),   
Suicides 1.5 (0.3, 6.5) 
Accidents  2.7 (1.9, 3.7), especially  
Drowning 12.8 (7.0, 23.2).   
 










SMR DD & epilepsy 4.0 (3.6 to 4.3)  
DD no epilepsy 1.9 (1.8 to 2.0) 
Suicide DD & epilepsy 0.3 (ns) 
Suicide DD no epilepsy 0.2 (ns) 
Drowning those with recent seizures 35.9 (ns)   
Drowning no history of epilepsy 2.3 (ns)  
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Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   





1985 to 1995 
People with DD 
ascertained at 10 
years of age from 
schools, hospitals, 
other health & social 
services, total 1584 
with DD aged 10-19 of 
whom 67% had 
'mental retardation'.  
34% had epilepsy, 
number with ID & 
epilepsy ns 





well as an 
additional 










SMRMR  Epilepsy & additional DD 13.2 (7.6 to 21.5),  










1989 to 1992  
Those with refractory 
epilepsy under 50 
years of age identified 
in General Practice 
Research Database 
(GPRD) (> 4 million 
people registered with 
GP) - ID those with 
computer recorded 




for two or 
more AEDs 
within 30 days 












SUDEP  1.4 (0.3-8.0)  
 
(Paper uses acronym ‘SUD’ but criteria used are 






cohort 1987 to 
1992 
All registered with 
Board for Provision & 
Services to the 
Mentally Retarded 
(BPSMR) in one 
province, almost total 
ID population in study 
area.  Total sample of 
1478.  Males 821, 
females 657.  All 
levels of ID & ages.  
Of these 296 with 
active epilepsy 
Active 
epilepsy.  Last 
SZ in last 5 
years &/or on 
AEDs  









SMR Entire ID sample 2.0 (1.7 to 2.3).  
ID with epilepsy 5.0 (3.3 to 7.5) 
ID, epilepsy & CP 5.8 (3.4 to 9.8).   
SZ free in preceding year 2.0 (0.9 to 4.7)   
SZ weekly or fewer 4.7 (2.8 to 7.9),  
SZ more than weekly 16.8 (10.7 to 26.5).   
Partial SZ without SZ secondarily generalized 3.7 (1.0 
to 13.6)  
SZ secondarily generalized 5.0 (2.3 to 11.0)  
SZ generalized from onset 8.1 (5.7 to 11.5) 
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Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   
All cause mortality unless otherwise stated 
Hermon, 
Alberman, 







followed up to 
July 1997 
1425 persons with DS 
born before 1990 
identified from records 
of five collaborating 
genetic units in 
England and 
Scotland, total 346 
deaths 













SMR Epilepsy as cause of death 17.3 (7.4 to 34.0) 
Hill, Gridley, 
Cnattingius 





data linked to 
registries of 
mortality & 
cancer for those 
with diagnosis 
of DS at 
discharge 1965 
to 1993 Sweden 




Combined cohort of 
4872 from Sweden & 
Denmark with hospital 
discharge diagnosis of 
DS who survived at 
least 12 months after 
date of discharge, 
total 742 deaths 













SMR Epilepsy as cause of death 30.4 (13.9 to 57.7) 
Kiani, Tyrer, 
Jesu et al 
2014 
England Retrospective 




notes of 20 
SUDEP cases 
investigated 
5391 adults (20+) with 




(LIDR) of whom 1027 



























SMR Men with ID 2.2 (2.0 to 2.4)  
Women with ID 2.8 (2.5 to 3.1).  
Men with ID & epilepsy 3.2 (2.7 to 3.8)  
Women with ID & epilepsy 5.6 (4.6 to 6.7)  
SUDEP men with ID 37.6 (21.9 to 60.2)  
SUDEP women with ID 52.0 (23.8 to 98.8) 
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Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   
All cause mortality unless otherwise stated 
Mölsä 1994 Finland Cohort followed 
for 20 years 
1971 to 1991 
212 Inpatients & 217 
outpatients of a centre 
for 'mentally 
handicapped', 53% & 
54% with epilepsy 
respectively.  All ages 
& from mild to 
profound ID.   Total 88 
deaths, 53 inpatients 

















Outpatients 1.79 (0.76 to 4.25),  
Inpatients 0.87 (0.48 to 1.61) 
 
Outpatients subdivided by type of residence, for those 




Garner et al 
1995 
England Cohort enrolled 
at special 





310 pupils with 
epilepsy & ID at 
special residential 
school for children & 
adolescents with 




more than one 
seizure a 
week 
310 of whom 
28 deaths, 






SMR All cause 15.9 (10.6-23.0) 
 
All 14 sudden deaths occurred when the pupils were 
not under the close supervision of the school and most 




US Review of 
records of 
population-




All children age 1 
month to 17 years 
diagnosed with 
epilepsy while 
resident in one County 
(n=467).  ‘Abnormal 
cognitive function’ in 
192 (109  mild to 
moderate ID; 83 









192 of whom 
15 died 
275 of whom 
1 died 
Those 






In multivariable Cox regression model only abnormal 




Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   






cohort 1984 to 
2007 
316 people (ages 18–
69 years) living in an 
institution where 90% 
judged to have severe 
ID. Excludes those 
with severe motor 















2.39 (1.17 to 4.92) 
 




Vesala et al 
2000 
Finland Prospective 
cohort 1963 to 
1997 
Nationwide population 
based sample of 2366 
people with ID with 35 
year follow-up (61 689 










Cox regression found epilepsy was associated with 
reduced survival for the following: 
  
2-9 years old in 1963 ns (0.38-0.84) 





cohort 1964 to 
2002 
All children < 16 yrs  
in catchment area of a 
University Hospital in 
1964 with a diagnosis 
of 
epilepsy (n=245), 
number with 'severe 
cognitive impairment' 
not stated 




based on ILAE 
ns Total sample 
245, number 











For those with remote symptomatic epilepsy (n=123 of 
whom 45 deaths), severe cognitive impairment was 
associated with increased mortality  4.1 (2.0 to 8.3)   
 




Author Country Design & 
study period 









Statistic Results (& 95% confidence interval).   




al 2003 (see 




records 1988 to 
1999 
People with mild DD 
receiving services 
from State of 
California, 71% with 
‘other DD’ of whom 
majority had mild or 
moderate ID.  
Excluded if unable to 
walk well alone at 
least 20 feet & 
balance well, unable 
to climb stairs without 
support, severe or 
profound ID.  
Degenerative 

























SMR Epilepsy no SZ in last year 1.1 (0.8 to 1.5)  
Seizures not GTC in last year 2.4 (1.9 to 3.0),  
GTC seizures in last year 2.9 (2.4 to 3.4),  
Status epilepticus in last year 3.7 (2.5-5.4)  
 
Compared to the California general population those 






cohort 1991 to 
1996 
Patients at 3 epilepsy 
centres enrolled 
prospectively, ID 
defined as Full-Scale 
Wechsler IQ < 70 or 
not considered 
testable.  Total 4,578 
patients (16,463 
patients years).  20 
SUDEP cases out of 
111 deaths.   
ns, enrolled at 
epilepsy 
centre 
ns, 7 of 20 
SUDEP 
cases were 
those with ID 



















ID a risk factor for SUDEP after adjustment for SZ 
frequency, OR 4.6 (1.2-18.0) 
 
c Computed from available data, not reported directly; RR study reports ‘relative risk’ or ‘rate ratio’ based on Cox Proportional Hazards Regression, entered in the 
table as ‘hazard ratio’; MR study reports ‘mortality ratio’, description of method consistent with SMR. 
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AED antiepileptic drug: CP cerebral palsy: DD developmental disabilities; DS Down syndrome; GPRD general practice research database; GTC generalised tonic-
clonic; ICD-9 International Classification of Diseases 9th Edition; ID intellectual disabilities; ILAE International League Against Epilepsy; ns not stated; SMR 








Appendix One: Electronic Search Strategy 
 
MEDLINE AND CINAHL 
Limits: 1990; English; Human 
(TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or disab* or 
deficien* or handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or handicap*) ) OR 
TI development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI "Down* syndrome" OR 
(MH "Developmental Disabilities/EP/MO") OR (MH "Intellectual Disability+/EP/MO") OR (MH 
"mentally disabled persons")) OR (AB ( learning N1 (disab* or difficult* or handicap*) ) OR AB ( 
mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) OR AB ( intellectual* N1 
(disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB ( multipl* N1 (handicap* 
or disab*) ) OR AB"Down* syndrome") 
AND 
(MH "Epilepsy+/MO/EP") OR ( TI epilep* OR TI seizure* OR TI convulsi* OR AB epilep* OR AB 
seizure* OR AB convulsi*) 
AND 
(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB incidence OR AB prevalence OR AB 
mortality OR AB death) OR (MH "Incidence") OR (MH "Prevalence") OR (MH "Mortality+") 
PSYCINFO 
Limits: 1990, Peer review, English, Exclude dissertations 
DE "Epilepsy" OR DE "Epileptic Seizures" OR (DE "Seizures" OR DE "Audiogenic Seizures" OR DE 
"Epileptic Seizures" OR DE "Grand Mal Seizures" OR DE "Petit Mal Seizures" OR DE "Status 





(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB incidence OR AB prevalence OR AB 
mortality OR AB death) OR DE "Epidemiology" OR DE “death and dying” OR DE “mortality rate” 
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DE "Intellectual Development Disorder" OR DE "mental retardation" OR DE "developmental 
disabilities" OR (TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or 
disab* or deficien* or handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or 
handicap*) ) OR TI development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI 
"Down* syndrome") OR AB ( mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) 
OR AB ( intellectual* N1 (disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB ( 
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